menu
    • menu

    Company profile for Orion Pharma

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    To be regarded as a world-class pharmaceutical company in the field of generic finished products. To improve people's health and achieve stakeholders' satisfaction by manufacturing and marketing pharmaceutical finished products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orion PharmaBangladesh Flag
    Country
    Country
    Bangladesh
    Address
    Address
    Orion House, 153-154 Tejgaon Industrial Area Dhaka-1208
    Telephone
    Telephone
    +88 02 8870133
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.orionpharmabd.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orion Pharma Launches Ph2 TEADES Trial of ODM-212 in MPM & EHE
    Orion Pharma Launches Ph2 TEADES Trial of ODM-212 in MPM & EHE

    08 Jan 2026

    // PRESS RELEASE

    https://www.orionpharma.com/newsroom/all-news/releases/press-releases/2026/orion-pharma-announces-the-initiation-of-teades-phase-2-trial-of-odm-212-in-malignant-pleural-mesothelioma-mpm-and-epithelioid-hemangioendothelioma-ehe/

    PRESS RELEASE
    08 Jan 2026
    Share Share
    X-Chem, Orion Pharma collaborate to speed up Drug Discovery
    X-Chem, Orion Pharma collaborate to speed up Drug Discovery

    30 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/30/3071505/0/en/X-Chem-Expands-Strategic-Collaboration-With-Orion-Pharma-to-Accelerate-Orion-s-Early-Drug-Discovery-From-Hit-to-Candidate.html

    GLOBENEWSWIRE
    30 Apr 2025
    Share Share
    Orion To Release H1 2024 Report And Host Webcast On August 8
    Orion To Release H1 2024 Report And Host Webcast On August 8

    25 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/25/2918576/0/en/Orion-publishes-Half-Year-Financial-Report-for-January-June-2024-and-holds-a-webcast-on-8-August-2024.html

    GLOBENEWSWIRE
    25 Jul 2024
    Share Share
    Merck & Co. opts in on Orion's hormone-dependent cancer candidates
    Merck & Co. opts in on Orion's hormone-dependent cancer candidates

    01 Jul 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/merck-co-opts-orions-hormone-dependent-cancer-candidates

    FIERCE BIOTECH
    01 Jul 2024
    Share Share
    Proteros and Orion Pharma agree on a long-term multi-target collaboration
    Proteros and Orion Pharma agree on a long-term multi-target collaboration

    06 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/06/2738041/0/en/Proteros-biostructures-and-Orion-Pharma-agree-on-a-long-term-multi-target-collaboration-including-the-assembly-of-a-joint-novel-and-unique-HTS-small-molecule-screening-library-with.html

    GLOBENEWSWIRE
    06 Sep 2023
    Share Share
    Orion Group Financial Statement documents 2022
    Orion Group Financial Statement documents 2022

    28 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/28/2616685/0/en/Orion-Group-Financial-Statement-documents-2022-Corporate-Governance-Statement-and-Remuneration-Report-published.html

    GLOBENEWSWIRE
    28 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search